PN-943

· Protagonist Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PN-943, covering 2023-04-25 to 2023-04-25. Get the full timeline:

Most recent: Clinical Trial Update: PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) [Phase 2]